These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24190862)

  • 1. Wnt pathway in osteosarcoma, from oncogenic to therapeutic.
    Cai Y; Cai T; Chen Y
    J Cell Biochem; 2014 Apr; 115(4):625-31. PubMed ID: 24190862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt signaling pathway: implications for therapy in lung cancer and bone metastasis.
    Xi Y; Chen Y
    Cancer Lett; 2014 Oct; 353(1):8-16. PubMed ID: 25042867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt signaling in osteosarcoma.
    Lin CH; Ji T; Chen CF; Hoang BH
    Adv Exp Med Biol; 2014; 804():33-45. PubMed ID: 24924167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin pathway.
    Jiang Z; Jiang C; Fang J
    Biochem Biophys Res Commun; 2018 Jan; 495(1):238-245. PubMed ID: 29108989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt pathway, an essential role in bone regeneration.
    Chen Y; Alman BA
    J Cell Biochem; 2009 Feb; 106(3):353-62. PubMed ID: 19127541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma.
    Cai Y; Mohseny AB; Karperien M; Hogendoorn PC; Zhou G; Cleton-Jansen AM
    J Pathol; 2010 Jan; 220(1):24-33. PubMed ID: 19882675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?
    Danieau G; Morice S; Rédini F; Verrecchia F; Royer BB
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Wnt signaling represses the proapoptotic proteoglycan syndecan-2 in osteosarcoma cells.
    Dieudonné FX; Marion A; Haÿ E; Marie PJ; Modrowski D
    Cancer Res; 2010 Jul; 70(13):5399-408. PubMed ID: 20530678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functionalized curcumin analogs as potent modulators of the Wnt/β-catenin signaling pathway.
    Leow PC; Bahety P; Boon CP; Lee CY; Tan KL; Yang T; Ee PL
    Eur J Med Chem; 2014 Jan; 71():67-80. PubMed ID: 24275249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt/β-Catenin Signaling Activates Expression of the Bone-Related Transcription Factor RUNX2 in Select Human Osteosarcoma Cell Types.
    Vega OA; Lucero CMJ; Araya HF; Jerez S; Tapia JC; Antonelli M; Salazar-Onfray F; Las Heras F; Thaler R; Riester SM; Stein GS; van Wijnen AJ; Galindo MA
    J Cell Biochem; 2017 Nov; 118(11):3662-3674. PubMed ID: 28370561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
    Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
    Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant activation of Wnt/β-catenin signaling pathway contributes to the sequential progression of DMBA-induced HBP carcinomas.
    Vidya Priyadarsini R; Senthil Murugan R; Nagini S
    Oral Oncol; 2012 Jan; 48(1):33-9. PubMed ID: 21924667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt Signaling in Osteosarcoma.
    Singla A; Wang J; Yang R; Geller DS; Loeb DM; Hoang BH
    Adv Exp Med Biol; 2020; 1258():125-139. PubMed ID: 32767238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCAR2 promotes a malignant phenotype of osteosarcoma through Wnt/β-catenin-dependent transcriptional activation of SPARC.
    Chen L; Zhou SJ; Xu Y; Liao QM; Zou YS; Pei H
    Biochem Biophys Res Commun; 2021 Nov; 580():67-73. PubMed ID: 34624572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting WNT5B and WNT10B in osteosarcoma.
    Miranda-Carboni GA; Krum SA
    Oncotarget; 2024 Aug; 15():535-540. PubMed ID: 39102216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
    Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt Signaling in Ewing Sarcoma, Osteosarcoma, and Malignant Peripheral Nerve Sheath Tumors.
    Pridgeon MG; Grohar PJ; Steensma MR; Williams BO
    Curr Osteoporos Rep; 2017 Aug; 15(4):239-246. PubMed ID: 28647886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropilin-2 expression is inhibited by secreted Wnt antagonists and its down-regulation is associated with reduced tumor growth and metastasis in osteosarcoma.
    Ji T; Guo Y; Kim K; McQueen P; Ghaffar S; Christ A; Lin C; Eskander R; Zi X; Hoang BH
    Mol Cancer; 2015 Apr; 14():86. PubMed ID: 25890345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The canonical Wnt-beta-catenin pathway in development and chemotherapy of osteosarcoma.
    Li C; Shi X; Zhou G; Liu X; Wu S; Zhao J
    Front Biosci (Landmark Ed); 2013 Jun; 18(4):1384-91. PubMed ID: 23747891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt inhibitory factor-1 functions as a tumor suppressor through modulating Wnt/β-catenin signaling in neuroblastoma.
    Zhang J; Zhou B; Liu Y; Chen K; Bao P; Wang Y; Wang J; Zhou Z; Sun X; Li Y
    Cancer Lett; 2014 Jun; 348(1-2):12-9. PubMed ID: 24561119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.